Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00001367 · ClinicalTrials.gov registry record
Diagnosis and History Study of Patients With Different Neurological Conditions
A clinical trial, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- Completed
- Registry status
- 3,813
- Enrollment target
NCT00001367: Completed study, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
NCT00001367 is a clinical trial that has completed, run by National Institute of Neurological Disorders and Stroke (NINDS). The registered enrollment target is 3,813 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00001367 has completed, sponsored by National Institute of Neurological Disorders and Stroke (NINDS).
- COMPLETED
- Registry status
- 3,813 participants
- Enrollment target
Study Summary
This protocol is a screening and natural history protocol, which allows for evaluation of patients and families where neurological conditions are present for enrollment into other studies and will also be used to screen healthy volunteers to create a pool of potential future HV matches for HMCS protocols. Through diagnostic evaluations, data will be collected for research use in this study.
Primary Outcome
The goal is to screen patients with neurological conditions and family members of patients with neurological conditions for enrollment in additional research protocols. No investigational treatments will be administered on this protocol and the NIH physicians will be playing a consultative role to the patient s primary physician.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 3,813 participants |
| Start Date | 1993-09-30 |
What the finished NCT00001367 record still lists
NCT00001367 is an observational study that tracks outcomes without assigning an intervention. Its 3,813 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 0 interventions.
NCT00001367 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00001367 about?
NCT00001367 is a clinical study titled "Diagnosis and History Study of Patients With Different Neurological Conditions". This protocol is a screening and natural history protocol, which allows for evaluation of patients and families where neurological conditions are present for enrollment into other studies and will also be used to screen healthy volunteers to create a pool of potential future HV matches for HMCS pr...
What is the current status of trial NCT00001367?
This trial is currently completed. The enrollment target is 3,813 participants. The study started on 1993-09-30.
Who is sponsoring clinical trial NCT00001367?
This trial is sponsored by National Institute of Neurological Disorders and Stroke (NINDS), which has 567 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04573660 · 3,784 participants
Abbott Vascular Medical Device Registry
- NCT07087613 · 3,850 participants
Deep Learning Detection of Pulmonary Hypertension and Low Ejection Fraction Via Digital Stethoscope and 3-Lead ECG
- NCT06172660 · 3,750 participants
Real-World Effectiveness of Perinatal RSV Immunoprophylaxis
- NCT06298253 · 3,750 participants · NA
Behavioral Economics to Implement a Traffic Light Nutrition Ranking System: Study 2
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI